Clin2
NCT07668466Possibly a fitNot yet recruiting

Study of rhGDF-6 for chronic low back pain from disc degeneration

Disc Degenerative DiseaseBack Pain

Treatments studied

Part of Bones, joints & muscles, Pain clinical trials.

This trial tests a new drug called rhGDF-6 injected into the discs of your spine to help repair them. If you have had low back pain for at least 3 months despite trying other non-surgical treatments, and your MRI shows disc wear or changes, this study may offer a new option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must have low back pain that bothers you a fair bit or more, and have tried at least 3 months of non-surgical treatments like physical therapy or medication.
  • Your MRI must show disc degeneration (grades 2-4) or signal changes at one or two discs in your lower back.
  • You must be 18 or older and willing to come back for follow-up visits.
  • You cannot have had any prior surgery on the painful discs or other treatments like steroid injections into those discs.
  • You must not have certain other spine problems like a herniated disc pressing on a nerve, severe arthritis in the back joints, or cancer.
  • You cannot be pregnant, breastfeeding, or planning to become pregnant during the first year of the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06144970Not yet recruiting· Phase 1
Testing a new gene therapy for chronic low back pain

This trial tests a new gene therapy called TG-C for people with chronic low back pain caused by degenerative disc disease. The goal is to see if it is safe and tolerable, and it might offer a new treatment option for those who haven't found relief from other therapies.

NCT06715085Recruiting· Phase 4
PRGF injections for chronic low back pain

This trial tests whether injections of a blood-based treatment called PRGF can help people with long-term low back pain caused by worn discs. It is for those who haven't gotten relief from standard treatments like medication.

Vitoria-Gasteiz, Alava
NCT07254806Recruiting· Phase 3
Cell therapy for low back pain from disc disease

This study tests if injecting a special cell therapy into a damaged spinal disc can reduce chronic low back pain. It is for people who have had low back pain for at least 6 months and haven't gotten enough relief from other treatments like physical therapy or pain medication.

Birmingham, Alabama
NCT05287867Recruiting
Study for painful degenerative disc disease treatment

This trial is testing a treatment approach for people with long-lasting, painful worn-out discs in the lower back (and sometimes leg pain). It looks for people who tried common non-surgical options without enough relief and who may be headed toward a lumbar procedure.

Broomfield, Colorado
NCT06778447Recruiting
Disc injection for chronic low back pain

This study tests whether injecting a special disc material (nucleus pulposus allograft) into the damaged discs of your lower back can safely reduce pain and improve function. It's for people with long-term, moderate to severe low back pain from disc disease that hasn't gotten better with other treatments.

Napa, California
NCT06011551Recruiting
Gel injection for painful lumbar discs

This trial tests a gel (HYDRAFIL-D) injected into painful discs in your lower back to see if it relieves pain. It's for people whose back pain hasn't improved with other treatments.

Birmingham, Alabama

Hear when a new Back Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.